Clindamycin’s most common side effect is diarrhea, which affects 10 to 30 percent of people who take it by mouth. Beyond digestive issues, this antibiotic can cause skin reactions, liver changes, and in rare cases, a serious gut infection that carries an FDA boxed warning. The side effects you experience depend partly on whether you’re taking clindamycin as a pill, getting it through an IV, or applying it to your skin.
Digestive Side Effects Are the Most Frequent
Diarrhea and abdominal pain are classified as common side effects, meaning they occur in roughly 1 to 10 percent of users in formal reporting, though clinical experience puts diarrhea rates as high as 30 percent. Nausea, vomiting, and loss of appetite also happen but are considered uncommon, affecting fewer than 1 in 100 people.
Most of this diarrhea is simply “antibiotic-related,” meaning the drug disrupts the normal balance of bacteria in your gut and your digestion gets thrown off temporarily. It typically resolves once you finish the course. Taking clindamycin with food or a full glass of water can reduce stomach upset for some people. Probiotics are sometimes recommended to restore gut bacteria during antibiotic treatment, though the evidence on whether they meaningfully reduce symptoms is mixed. They’re unlikely to cause harm unless you have a weakened immune system.
The C. Difficile Risk Is Serious
Clindamycin carries an FDA boxed warning, the most serious type, specifically about a gut infection caused by a bacterium called Clostridioides difficile (C. diff). This isn’t ordinary diarrhea. C. diff overgrows when antibiotics wipe out the normal bacteria keeping it in check, and it produces toxins that inflame and damage the colon. About 6 percent of clindamycin users develop C. diff colitis.
Among all commonly prescribed antibiotics, clindamycin carries the highest relative risk for this infection. A large study comparing 27 different antibiotics found that clindamycin had an odds ratio of roughly 25, meaning people exposed to it within 30 days were about 25 times more likely to develop a community-associated C. diff infection than those not taking antibiotics. That risk remained elevated even at 90 days after exposure.
The warning signs that distinguish C. diff from ordinary antibiotic diarrhea include watery diarrhea occurring three or more times a day, fever, severe abdominal cramping, and blood or mucus in your stool. These symptoms can appear while you’re taking the drug or up to two months after you finish it. If you develop persistent or worsening diarrhea during or after a clindamycin course, that warrants prompt medical attention because C. diff colitis can progress to life-threatening severity.
Skin Reactions Range From Mild to Rare
A generalized rash resembling measles (flat, red, and widespread) is an occasional side effect of oral clindamycin. This type of rash is typically not dangerous, though it can be uncomfortable and may signal a mild allergic response.
Severe skin reactions like Stevens-Johnson syndrome and DRESS syndrome (a delayed drug reaction involving fever, rash, and organ inflammation) have been reported but are classified as extremely rare. These conditions involve blistering of the skin and mucous membranes and require emergency care. Signs include a spreading painful rash, blisters on the mouth or eyes, fever, and skin that peels in sheets.
Side Effects From Topical Clindamycin
When clindamycin is applied to the skin for acne, the side effects are mostly local. In one comparative study, about 40 percent of people using topical clindamycin gel reported some kind of skin reaction. Redness (erythema) was the most common complaint. Burning and scaling occurred less frequently. These local reactions are generally mild and tend to improve as your skin adjusts over the first few weeks of use.
Topical clindamycin is absorbed into the body in small amounts, so the systemic risks like C. diff infection still exist in theory, though they are far less likely than with oral or IV forms.
Effects on the Liver
Clindamycin can cause temporary, mild elevations in liver enzymes, particularly when given intravenously. These elevations are typically subclinical, meaning they show up on blood tests but don’t cause symptoms. Acute liver injury with symptoms like jaundice from oral clindamycin is rare. When it does occur, it has generally been reversible after stopping the medication.
Concerns During Breastfeeding
Clindamycin passes into breast milk. Studies have detected it in milk at concentrations of about 0.7 to 3.8 micrograms per milliliter after standard doses. There is at least one reported case of an infant developing bloody stools while the mother was taking clindamycin, though a direct cause-and-effect link wasn’t confirmed. The primary concern is that the drug could alter gut bacteria in a nursing infant, potentially causing diarrhea. If you’re breastfeeding and prescribed clindamycin, monitoring your infant for loose stools or blood in the stool is important.
Interactions With Surgical Anesthesia
One lesser-known property of clindamycin is that it can enhance muscle relaxation. It blocks neuromuscular conduction, which means it strengthens the effects of muscle-relaxing drugs used during surgery. This interaction can prolong the period after surgery when your muscles haven’t fully regained their strength, potentially affecting your ability to breathe independently. If you’re scheduled for a procedure involving general anesthesia, your surgical team needs to know you’re taking clindamycin. This interaction has been linked to cases of respiratory depression after surgery, particularly when combined with opioid pain medications.
Allergic Reactions
True allergic reactions to clindamycin, including hives, swelling, and anaphylaxis, are possible but uncommon. One specific note: the 75 mg and 150 mg capsules contain a yellow dye called tartrazine, which can trigger allergic-type reactions (including bronchial asthma) in people who are sensitive to aspirin. If you have a known aspirin allergy, this is worth flagging with your pharmacist.
Why Clindamycin Is Still Prescribed
Given the side effect profile, particularly the C. diff risk, clindamycin is generally reserved for infections where other, less risky antibiotics aren’t appropriate. It remains a valuable option for serious skin and soft tissue infections, bone infections, dental infections, and certain cases involving MRSA. The FDA label explicitly states it should not be used for mild infections like most upper respiratory infections where safer alternatives exist. Your prescriber has weighed the severity of your infection against these risks, and completing the course as directed remains important for treating the infection effectively.